Related Experiment Video
Updated: Apr 4, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica
1From the Department of Radiology and Tianjin Key Laboratory of Functional Imaging (Q.W., N.Z., W.Q., C.Y.).
Neuromyelitis optica patients show reduced gray matter volume, particularly in the frontal and temporal cortices and thalamus. This gray matter loss is linked to cognitive deficits and increased disease severity.
Area of Science:
- Neuroimaging
- Neurology
- Neuroimmunology
Background:
- Neuromyelitis optica (NMO) is an autoimmune disease targeting the central nervous system.
- The presence of gray matter impairment in NMO and its link to cognitive deficits are not well understood.
Purpose of the Study:
- To investigate gray matter volume reductions in NMO patients.
- To explore the association between gray matter changes and cognitive decline in NMO.
Main Methods:
- Structural MRI was used to assess gray matter volume in 50 NMO patients and 50 healthy controls.
- Cognitive assessments evaluated memory, processing speed, and verbal fluency.
- Correlations between gray matter volume, cognitive scores, and clinical variables were analyzed.
Main Results:
- NMO patients exhibited a 5.21% reduction in whole-brain gray matter volume compared to controls (P < .001).
- Significant gray matter reductions were observed in the frontal and temporal cortices and right thalamus (P < .05).
- Gray matter reductions in these areas correlated with disease severity and cognitive impairments in NMO patients.
Conclusions:
- Gray matter volume reduction is a significant finding in NMO.
- These reductions are associated with both cognitive impairment and disease severity in NMO patients.
More Related Videos
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014